Sam Colin

Sam Colin, MD, is a Partner and Portfolio Manager. He is a value-oriented stock picker whose primary goal is to preserve and grow clients' capital by focusing on companies that he believes have highly favorable risk-reward relationships. This attention to downside risk provided his client portfolios with meaningful protection in 2008 and, in his view, such attention remains a critical element in navigating periods of market turbulence.*

In addition to managing individual accounts, for over 20 years, Sam leveraged his medical training and investment research experience as the sole Portfolio Manager of First Manhattan's healthcare-specific private investment vehicles—First BioMed and First Health.

Sam joined First Manhattan in 1994 as a Research Analyst focused on the pharmaceutical and biotechnology industries. He holds an MD from Yale University School of Medicine and a BS from Brown University. He lives in Westchester, New York, with his wife and three children.

*Past performance does not guarantee future results.

Portfolio construction and management

First and foremost, Sam is concerned with capital preservation. His client portfolios, which are tailored to each individual's specific needs and risk tolerance, typically consist of approximately 25 stocks characterized by:

• Strong management, with a track record of disciplined execution.
• Good business selling at reasonable rates.
• Mispriced securities that are off the collective radar screens of sellside analysts.
• Special situations, including corporate restructurings and spin-offs.
• Companies that have catalysts for value creation, such as new product pipelines.
• Bargain opportunities that arise from disorderly selling in turbulent markets.